Skip to main content

Table 4 Late toxicities after concurrent chemoradiotherapy for bladder preservation

From: Upper Egypt experience in bladder preservation using concurrent chemoradiotherapy

Late toxicity* I II III IV
  Group A Group B Group A Group B Group A Group B Group A Group B
  13.3% 23.3% 33.3% 6.6% 0% 3.3% 0% 0%
  53.3% 23.3% 13.3% 13.2% 0% 6.6% 0% 0%
  16.6% 6.6% 6.6% 0% 0% 0% 0% 0%
  6.6% 3.3% 0% 3.3% 0% 0% 3.3% 0%
  1. *(NCI toxicity grading).